SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Journal of Psychopharmacology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hoffbrand, A.V.
Right arrow Articles by Wilkes, S.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hoffbrand, A.V.
Right arrow Articles by Wilkes, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Investigation of psychotropic drug-induced blood agranulocytosis

A.V. Hoffbrand

Department of Haematology, The Royal Free Hospital School of Medicine, Pond Street, Hampstead, London NW3 2QG, UK

P.A. Veys

Department of Haematology, The Royal Free Hospital School of Medicine, Pond Street, Hampstead, London NW3 2QG, UK

S. Wilkes

Department of Haematology, The Royal Free Hospital School of Medicine, Pond Street, Hampstead, London NW3 2QG, UK

Psychotropic drugs frequently cause agranulocytosis. It is therefore important that patients on these drugs who develop symptoms or signs of infection should have a full blood count performed, and if the neutrophil count is reduced, prompt withdrawal of the drug and, if necessary, immediate supportive care should be given to reduce the incidence of mortality. Once the patient has recovered, investigations can be performed to confirm the diagnosis and incriminate the responsible drug. It is imperative, in order that these tests may be performed, that serum samples are taken at the time of diagnosis of the neutropenic episode, throughout its course and during the recovery period.

Key Words: psychotropic drugs • agranulocytosis • side effects

Journal of Psychopharmacology, Vol. 6, No. 2, 222-224 (1992)
DOI: 10.1177/026988119200600215


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J PsychopharmacolHome page
J.G. Edwards
Methods of assessing unwanted effects of psychotropic drugs. General considerations and overview
J Psychopharmacol, January 1, 1992; 6(2): 191 - 197.
[PDF]



Advertisement